NeuroEpo Clinical Trials Show Promising Results in Slowing the Progression of Alzheimers

Published 1y ago - Cuba Business Report Staff

Cuba’s latest pharmaceutical innovation, NeuroEpo, shows promising results in slowing the progression of Alzheimer’s, a disease which affects a growing number of people worldwide. NeuroEpo is a neuroprotective treatment applied intranasally against Alzheimer’s... More »